Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-09-29

FDA Approved: VIGABATRIN — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved an original ANDA for Vigabatrin from Aurobindo Pharma Limited, enabling generic availability of the drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vigabatrin (Vigabatrin)

Snippet

ORIG AP for VIGABATRIN (VIGABATRIN)